Background/Aims: Pulse pressure (PP) is a predictor of adverse outcomes in patients on haemodialysis. Thus, the present study was conducted to assess the relationship between PP, estimated glomerular filtration rate (eGFR), and urine microalbumin/creatinine ratio (uACR) in Korean adults. 
; 2013-12EXP-03-5C). All participants in the survey signed an informed written consent form. Further information can be found in "The KNHANES VI Sample", which is available on the KNHANES website. The data from KNHANES is available on request by email if the applicant logs onto the "Korea National Health and Nutrition Examination Survey" website.
General Characteristics and Blood Chemistry
Research subjects were classified by sex (men or women), smoking (non-smoker or ex-smoker or current smoker), alcohol drinking (yes or no), and regular exercise (yes or no). In the smoking category, participants who smoked more than one cigarette a day, those who had previously smoked but do not presently smoke, and those who never smoked were classified into the current smoker, ex-smoker, and nonsmoker groups, respectively. Alcohol drinking was indicated as "yes" for participants who had consumed at least one glass of alcohol every month over the last year. Regular exercise was indicated as "yes" for participants who had exercised on a regular basis regardless of indoor or outdoor exercise. (Regular exercises was defined as 30 min at a time and 5 times/wk in the case of moderate exercise, such as swimming slowly, doubles tennis, volleyball, badminton, table tennis, and carrying light objects; and for 20 min at a time and 3 times/wk in the case of vigorous exercise, such as running, climbing, cycling fast, swimming fast, football, basketball, jump rope, squash, singles tennis, and carrying heavy objects). Anthropometric measurements included measurement of body mass index (BMI) and waist measurement (WM), as well as final measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP). Blood chemistries included measurements of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), triglycerides (TGs), fasting blood glucose (FBG), blood urea nitrogen (BUN), serum creatinine, urine microalbumin, and urine creatinine.
Glomerular filtration rate and urine microalbumin and pulse pressure Glomerular filtration rate (GFR) was estimated from the simplified equation developed using MDRD data: eGFR = 186.3 × (serum creatinine in mg/dL) -1.154 × age -0.203 × (0.742 for women) × (1.212 if African American) [21] . Decreased eGFR was classified as eGFR < 60 ml/min/1.73 m 2 . Urine microalbumin was measured with a turbidimetric assay (Albumin; Roche, Germany) using a Hitachi Automatic Analyzer 7600 (Hitachi, Japan). The urine creatinine was measured with a colorimetric assay (CREA; Roche, USA) using a Hitachi Automatic Analyzer 7600 (Hitachi, Japan). Elevated urine microalbumin/creatinine ratio (uACR) was classified as uACR ≥ 30 mg/g. PP was calculated as the difference between SBP and DBP. High PP was classified as PP ≥ 60 mmHg [22] .
Data Analysis
The collected data were statistically analyzed using SPSS WIN version 18.0 (SPSS Inc., Chicago, IL, USA). The distribution and average difference in clinical characteristics according to normal PP and high PP were calculated using chi-squared and an independent t test. The distribution and average difference in clinical characteristics according to normal, decreased eGFR, elevated uACR, and decreased GFR plus elevated uACR were calculated using chi-squared and an analysis of variance test. We conducted correlation analysis for eGFR and uACR and performed multivariate model adjusted only for confounders that were significantly associated with dependent variable (eGFR and uACR) in the correlation of eGFR and uACR. Multiple linear and logistic regression analysis models were constructed for the uACR levels and odds ratio of elevated uACR: model 1) was adjusted for age, gender, BMI, WM, TGs, HDL-C, FBG, SBP, DBP, eGFR, and either SBP and DBP or PP. Multiple linear and logistic regression analysis models were constructed for the eGFR levels and odds ratio of decreased eGFR: model 2) was adjusted for age, gender, smoking, drinking alcohol, regular exercise, BMI, WM, TC, TGs, HDL-C, FBG, uACR, and either SBP and DBP or PP. In the case of logistic regression for odds ratio of high PP, the 4 models constructed were: 1) non-adjusted; 2) adjusted for age and gender; 3) further adjusted for smoking, alcohol drinking, and regular exercise, BMI, and WM; 4) further adjusted for TC, TGs, HDL-C, and FBG. The significance level for all of the statistical data was set as p < 0.05.
Results

Clinical characteristics of research subjects
The clinical characteristics of the research subjects are shown in Table 1 , and 15.66 ± 101.89 mg/g in subjects with normal PP (n =8, 795), respectively. The prevalence rates of a decreased eGFR and elevated uACR were 2.3% (n = 199) and 6.7% (n = 564), respectively. Mean PP, eGFR, and uACR were 71.61 ± 11.28 mmHg, 85.90 ± 19.64 mL/min/1.73 m 2 , and 54.14 ± 291.70 mg/g in subjects with high PP (n =914), respectively. The prevalence rates of a decrease in eGFR and increased uACR were 8.5% (n = 78) and 22.6% (n = 207), respectively.
Bivariate correlation for eGFR and uACR
Bivariate correlation of eGFR and uACR are shown in Table 2 . Variables that positively correlated with eGFR were current drinker and HDL-C, and variables that inversely correlated with eGFR were uACR, SBP, DBP, PP, age, male, current smoker, regular exercise, BMI, WM, TC, Table 3 , 4, 5, and 6. We performed multivariate model adjusted only for confounders that were significantly associated with dependent variable (eGFR and uACR) in the correlation of eGFR and uACR. eGFR was inversely associated with SBP and PP but was positively associated with DBP in a multiple linear regression analysis for eGFR and uACR, after adjusting for related variables (Table  3 ). In contrast, uACR was positively associated with SBP and PP but was inversely associated with DBP ( (Table 8) .
Discussion
The present study investigated the association between PP and eGFR and uACR in Korean adults using data from the sixth KNHANES conducted in 2013-2014. Several findings of this study were key after adjusting some variables. eGFR was positively associated with SBP and inversely associated with DBP. In contrast, uACR was inversely associated with SBP and positively associated with DBP. In addition, enhanced PP was associated with a decrease in eGFR and an increase in the uACR.
CKD and CVD are closely associated due to clustering of several cardiovascular risk factors, including hypertension, diabetes mellitus, and dyslipidemia in patients with CKD, which results in an increase in CVD in patients with CKD [23, 24] . In a meta-analysis, the decrease in eGFR and increase in ACR were associated with an increased risk for cardiovascular mortality independently of each other and traditional risk factors, such as hypertension, diabetes mellitus, and hypercholesterolemia [25] . In the present study, the risk factors for CVD, such as SBP, PP, BMI, WM, TGs, and FBG, were higher in the decreased eGFR, elevated uACR, and decreased eGFR plus elevated uACR groups than those in the normal group, and DBP (except the elevated uACR group) and HDL-C were lower. It is important to monitor eGFR and the uACR in patients with progressive CKD. Microalbuminuria is a useful predictor of cardiovascular events [26] and may be useful as an early warning sign of diabetic nephropathy [27] . Diabetic nephropathy is a risk factor for ESRD because prevalence increases to about 40% in patients with ESRD [28, 29] . PP may be an important risk factor in the progression of both CKD and CVD. PP is a powerful predictor of arterial stiffness. Increased arterial stiffness leads to left ventricular hypertrophy [30] , and left ventricular hypertrophy is associated with mortality risk and cardiovascular events in patient with CKD and ESRD as demonstrated by higher rates of sudden cardiac death in these patients [31] . Therefore, Fernandez-Fresnedo et al. suggested that increase in PP is a significant predictor of risk for mortality and morbidity in patients with CKD including ESRD [32] . The mechanism linking PP and excretion of urinary albumin remains unclear. However, a long-term increase in PP could lead to endothelial dysfunction caused by microvascular damage in the kidney [33] . Then, endothelial dysfunction modifies glomerular permeability, which could lead to increased excretion of albumin [34] .
PP promotes the progression of vascular calcification [35] . Compared with the general population, patients with declining kidney function have a disproportionately high occurrence of vascular calcification. Vascular calcification in patients with CKD occurs Table 6 . Logistic regression analysis for the independent factors determining decreased eGFR, (n = 9,409) via osteoblastic-like cell differentiation of the vascular smooth muscle cells in the kidneys. Some studies reported that cyclic adenosine monophosphate, which is mediated by tumor necrosis factor-α, stimulates the osteoblastic differentiation of vascular smooth muscle cells in kidney [36, 37] . In other studies, high extracellular calcium and phosphate concentrations have induced the transformation of vascular smooth muscle cells into osteoblast-like cells and accelerated the processes of active vascular calcification [38, 39] . Currently, previous studies indicate inconsistent results in the association between PP and renal function. Some studies have shown that eGFR decreases as PP increases [40, 41] , whereas other studies have shown that PP and eGFR or albuminuria are unrelated [18, 19, 42] . The reason for these inconsistencies is unclear; however, previous findings may differ according to the race or country and subjects with or without diseases, such as CKD, [42] . In the present study, we found that uACR was positively associated with SBP (β = 0.152; p < 0.001) and was inversely associated with DBP (β = -0.062; p < 0.001). In contrast, eGFR was inversely associated with SBP (β = -0.170; p < 0.001) and was positively associated with DBP (β = 0.088; p < 0.001). Therefore, PP was associated with uACR (β = 0.118; p < 0.001) and eGFR (β = -0.134; p < 0.001) because PP is defined as the value between SBP minus DBP.
We examined the change in PP level and odds ratio of high PP when the decrease in eGFR and increase in uACR occurred simultaneously, and our findings are interesting. Our results show that the ORs of high PP in the decreased eGFR plus elevated uACR group [3.889 (95% CI, 2.519-6.004)] was higher than the decreased eGFR [1.484 (95% CI, 1.003-2.196)] or elevated uACR group [2.592 (95% CI, 2.085-3.223)]. Due to the strong synergistic interaction between decreased eGFR and increased uACR, when the decreased eGFR is combined with the increased uACR, the risk of CKD progression may be accelerated [45] . These results are similar to the study of Levey et al. They reported that the CVD mortality for the decreased eGFR plus elevated uACR group was higher (at least 2.8 times) than the decreased eGFR group (at least 1.5 times) or the elevated uACR group (at least 1.6 times) [5] . They suggested that the OR of ESRD for the decreased eGFR plus elevated uACR group was very much higher (at least 40 times) than the decreased eGFR group (at least 5.2 times) or the elevated uACR group (at least 3.8 times). Increased PP is well known that a strong predictor of mortality in patients with CKD and cardiovascular disease. We consider that PP may be a useful predictor for why mortality greatly increased when a decrease in eGFR was combined with an increase in the uACR. In addition, Increase of PP in general populations is a predictor of prevalence of CKD events. In the present study, increase of PP in general population was associated CKD and its complication. Therefore, if PP increases in general populations, it may be suspected the CVD and its events as well as CKD and its complications, and the monitoring of PP in a general population can be useful for early treatment of these diseases. However, the present study has some limitations. First, parathyroid hormone (PTH) and serum phosphate are important factors in renal function [46] [47] [48] . However, the data of the KNHANES VI (2013-2014) study failed to measure the PTH and serum phosphate. Second, because this study was cross-sectional, it had only limited ability to establish a causal relationship between PP and uACR and eGFR. Although the present study had limitations, this is the first study to report on the relationship between PP and eGFR and uACR in Korean adults. Therefore, more accurate results might be obtained by performing a cohort study.
Conclusion
The present study investigated the association between PP and eGFR and uACR in Korean adults using data from the sixth KNHANES conducted in 2013-2014. Enhanced PP was associated with a decreased eGFR and an increase in uACR in Korean adults. In addition, the PP increased greatly when a decrease in eGFR and an increase in uACR appeared simultaneously.
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